Bicycle Therapeutics

-$1.79 (-3.18%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCYC and other ETFs, options, and stocks.

About BCYC

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in developing a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. The firm utilizes its novel and proprietary phage display screening platform to identify bicycles.

CEO
Kevin Lee
Employees
87
Headquarters
Cambridge, Cambridgeshire
Founded
2009

BCYC Key Statistics

Market Cap
1.57B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
670.76K
High Today
$56.23
Low Today
$53.78
Open Price
$56.17
Volume
134.20K
52 Week High
$60.34
52 Week Low
$17.68

BCYC Earnings

-$0.83
-$0.55
-$0.28
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure